A Phase I/IIa, Open-Label, Dose-Escalation and Cohort-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CHO-A04 in Subjects With Advanced Solid Tumors
Latest Information Update: 11 Jul 2025
At a glance
- Drugs CHO A04 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors CHO Pharma
Most Recent Events
- 11 Jul 2025 New trial record